I agree with your opinion that the forces against Novavax's success are from very powerful and diverse organizations. But Novavax won't be unduly affected, as BioNTech was, in partnering with Pfizer, since they already have a partnership with Sanofi. In fact, I think NVAX will become a subsidiary of Sanofi in the near-term.
Market Data 
Markets 
AI
